Filing metadata

Accession number
0001104659-21-122510
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Oct 04, 2021
Reporting period
Sep 30, 2021
Description
Insider transaction

Explore SEC Filings Hub